Clinical Trial Update: Taste Alteration, Sarcopenia, and Malnutrition in Gynecologic Cancer Patients Receiving Carboplatin-Paclitaxel Chemotherapy

View source ↗

Summary

A completed clinical trial in gynecologic cancers evaluated taste alteration, sarcopenia, and malnutrition in patients treated with carboplatin-paclitaxel.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Ankara Etlik City Hospital | Conditions: Ovarian Cancer (OvCa), Fallopian Tube Cancers | Status: COMPLETED